Vaccination against viral hepatitis B in patients undergoing liver transplantation for hepatitis B-unassociated causes

Vaccination against viral hepatitis B in patients undergoing liver transplantation for hepatitis B-unassociated causes

To study efficiency of molgramostim as an adjuvant in HBV vaccination we randomized 18 pts after OLT due to non-HBV causes. Nine pts received GM-CSF (150 mcg of sc 24 h before 1st dose of vaccine). Other 9 pts received only vaccine. Both groups of pts did not differ in sex, age, immunosuppression an...

Full description

Bibliographic Details
Main Authors: V. E. Syutkin, A. A. Saliyenko, D. E. Syutkina, A. V. Chzhao
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:Трансплантология (Москва)
Subjects:
gm-csf
hbv
vaccination
liver transplantation
molgramostim
Online Access:https://www.jtransplantologiya.ru/jour/article/view/289

Similar Items

Similar Items